News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement
|Articles|November 1, 2019

Pharmaceutical Executive, 2020 Pipeline Report (PDF)

Click the title above to open Pharmaceutical Executive's 16th Annual Pipeline Report in an interactive PDF format.

Advertisement
External Link - Pharm Exec_2020 Pipeline Report.pdf

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Pharmaceutical Executive

Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer

ByNicholas Jacobus
October 29th 2025
Stock.adobe.com

FDA Announces New Biosimilar-Targeted Draft Guidance

ByMike Hollan
October 29th 2025
Stock.adobe.com

Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report

ByMike Hollan
October 29th 2025
Stock.adobe.com

Lilly Forms Partnership with NVIDIA to Create AI Supercomputer

ByNicholas Jacobus
October 29th 2025
Stock.adobe.com

Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings

ByNicholas Jacobus
October 29th 2025
Advertisement
Advertisement

Trending on PharmExec

1

Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings

2

FDA Announces New Biosimilar-Targeted Draft Guidance

3

Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report

4

Lilly Forms Partnership with NVIDIA to Create AI Supercomputer

5

Pharmaceutical Executive Daily: Lilly and NVIDIA Create AI Supercomputer

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us